I’m Becky Stevenson. I’m a director of Life Sciences in the Healthcare Corporate Banking Group
at Wells Fargo, and I lead up the East Coast team.
The role that I play with my companies is to really be a consultative advisor. My companies are
all early stage, venture-backed healthcare companies, trying to really bend the curve of science,
to really bring novel solutions that solve big problems in healthcare.
I think where Wells Fargo can make things less complex for a healthcare company is to
understand their lifecycle, and is to understand the challenges that they face, and then also
highlight issues that perhaps at their lifecycle they are not aware is coming.
We can sort of help be that expert to say, ‘We’ve seen this before. Here’s a few themes you
should be thinking about, and here’s some ways that we know people have addressed them in
What Wells Fargo’s bringing to the healthcare industry is a unique approach.
We’ve built relationships over the last several years with the venture capital firms, the
institutional investors, with the accountants and the lawyers and the other people who are in
and around the ecosystem beyond the companies themselves, and are being a point of
reference to bring those pieces together and support the development of these companies.
We work with emerging healthcare companies on the cutting edge of science. They’re trying to
develop the next thing that’s going to disrupt healthcare as we see it today, so what they value
about their relationship with our team is that we can take out some of the noise in the day to
day, and just focus on their vision, and what they can do to change healthcare of tomorrow.